• slider-dummy-1.jpg
  • image3.jpg
  • image4.jpg

Sandoz is a world leader in generic pharmaceuticals, finding innovative ways to making medicines affordable and accessible to more than 90 percent of the world’s population.

Learn more about our company
Visions and Values

News

Sandoz strengthens its biosimilars portfolio with acquisition of Pfizer’s biosimilar infliximab in EEA

February 12, 2016

Sandoz, a Novartis company and a global leader in biosimilars, announced today that it has acquired from Pfizer the rights for the development and commercialization of PF-06438179 (biosimilar infliximab) in the...

...

Our people are our greatest resource. We are always looking for new colleagues to share in our commitment to make the world a healthier place.

Learn more about careers at Sandoz

Watch our videos to discover more about the world of Sandoz and the generics market.

Visit our video gallery to watch the latest episode

FAQ

woman.jpg

We have collected the most important and frequently asked questions about our business.

Visit our frequently asked questions page